跳至主要内容
临床试验/JPRN-UMIN000039095
JPRN-UMIN000039095尚未招募未知

The efficacy of Dulaglutide for the coronary plaque in patiENts with type 2 diabetes mellitus Evaluated By optical coherence tomography: single-center, randomized, open-label, parallel group study. - DENEB study

Kobe University, department of cardiology0 个研究点目标入组 50 人开始时间: 2020年3月2日最近更新:
适应症

试验速览

阶段
未知
状态
尚未招募
发起方
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • (1)Type 1 diabetes mellitus. (2)Hemodialysis patients (3)Patients who have received one or more doses of glucagon-like peptide 1 receptor agonist. (4)Patients with allergic drug hypersensitivity to drugs to be used. (5)Patients who conflict with any of the warning contraindications listed. (6)Pregnant women and pregnant or lactating patients. (7)Familial hypercholesterolemia homozygote. (8)Patients with a history of gastrointestinal injury, pancreatitis and ileus. (9)Others Patients judged inappropriate by the doctor in charge of this exam.

研究者

发起方
Kobe University, department of cardiology

相似试验